Austin Center RADIATION Oncology

Medications and Prostate Cancer

medications

At the Austin Center for Radiation Oncology, we regularly treat men with localized and advanced prostate cancer. Along with radiation, immunotherapy, and Xofigo, Dr. Garza may prescribe or make a recommendation for additional medications for men with prostate cancer when appropriate. Below is a list of medications that may be prescribed or recommended to our patients, and how they are used for cancer treatment. These medications are indicated for men who have testosterone levels that continue to rise after other treatments, while others are for men who have prostate cancer that has moved into the bone. Not every patient treated at the Austin Center for Radiation Oncology will be prescribed these medications. Dr. Garza will discuss these medications with patients if they are applicable to their treatment and communicate any recommendations to their attending Urologist.

Medications

Erleada – When fighting prostate cancer, it is important to lower testosterone levels in men. Oftentimes, this is readily achieved by taking medications designed for that purpose. Erleada is indicated for men who have localized prostate cancer (it has not spread to other parts of the body), and whose testosterone levels continue to rise after having utilized pharmaceutical and surgical options.

Zytiga – This medication is prescribed for men who have metastatic castration-resistant or castration-sensitive prostate cancer. When Zytiga is prescribed, it is used along with prednisone. Metastatic cancer means that it has spread outside the prostate capsule into other parts of the body.

Yonsa – This medication is prescribed for men with metastatic castration-resistant prostate cancer in combination with methylprednisolone.

Xgeva – This medication is prescribed for men with advanced prostate cancer that has spread into the bone. The goal of this medication is to help prevent bones from weakening and breaking down.

Prolia – This medication is prescribed for men undergoing androgen deprivation therapy. Prolia is used to stop bone-removing cells in order to protect bones from breaking down and bone fracture.

Xtandi – This medication is similar to Erleada. Xtandi is prescribed to men with metastatic castration-resistant and localized prostate cancer whose testosterone levels continue to rise after pharmaceutical and surgical treatments.


Contact the Austin Center for Radiation Oncology to schedule a consultation with Dr. Richard Garza.